comparemela.com

Latest Breaking News On - Vigil neuroscience inc - Page 7 : comparemela.com

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vigil Neuroscience (NASDAQ:VIGL) Stock Price Down 0 3%

Vigil Neuroscience, Inc. (NASDAQ:VIGL – Get Free Report)’s share price was down 0.3% during trading on Monday . The company traded as low as $3.52 and last traded at $3.59. Approximately 74,794 shares changed hands during mid-day trading, an increase of 27% from the average daily volume of 58,771 shares. The stock had previously closed […]

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference

WATERTOWN, Mass., Nov. 22, 2023 Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,.

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference

Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Positive interim results announced in phase 2 trial of leukoencephalopathy drug

Positive interim results announced in phase 2 trial of leukoencephalopathy drug
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.